Research graph
References from Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [ 177 Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [ 68 Ga]Ga-PSMA PET. Local targets link to admitted publications; unresolved targets remain external evidence.
10.2967/jnumed.125.270358
10.2967/jnumed.125.270358 · External reference
177Lu-PSMA treatment monitoring through serial fast whole-body tomoscintigraphies recorded with a latest-generation CZT-camera
10.1097/rlu.0000000000004811 · 2023 · External reference
10.2967/jnumed.124.267665
10.2967/jnumed.124.267665 · External reference
10.2967/jnumed.122.264398
10.2967/jnumed.122.264398 · External reference
10.2967/jnumed.122.264677
10.2967/jnumed.122.264677 · External reference
Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study
10.1007/s00259-023-06536-2 · 2024 · External reference
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting
10.1007/s00259-023-06176-6 · 2023 · External reference
Feasibility of 177Lu therapy monitoring using fast whole-body SPECT acquisitions provided by a high-speed 360° CZT camera
10.1097/rlu.0000000000003169 · 2020 · External reference
10.2967/jnumed.124.268910
10.2967/jnumed.124.268910 · External reference
10.1097/mnm.0000000000000079
10.1097/mnm.0000000000000079 · External reference
10.1016/s1470-2045(22)00605-2
10.1016/s1470-2045(22)00605-2 · External reference
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)
10.1177/17588359231156392 · 2023 · External reference
Ultra-fast whole-body bone tomoscintigraphies achieved with a high-sensitivity 360° CZT camera and a dedicated deep-learning noise reduction algorithm
10.1007/s00259-023-06558-w · 2024 · External reference
10.2967/jnumed.121.263072
10.2967/jnumed.121.263072 · External reference
Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatment
10.1186/s40658-023-00576-1 · 2023 · External reference
10.1007/s00259-022-05727-7
10.1007/s00259-022-05727-7 · External reference
Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
10.1186/s40658-023-00586-z · 2023 · External reference
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
10.1007/s00259-024-06718-6 · 2024 · External reference
10.2967/jnumed.119.233411
10.2967/jnumed.119.233411 · External reference
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
10.1186/s40658-020-00311-0 · 2020 · External reference
Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry
10.3389/fnume.2023.1291253 · 2023 · External reference
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617
10.1007/s00259-020-04723-z · 2020 · External reference
